Organon & Co. — Director's Dealing 2021

Aug 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2021-08-05

Reporting Person: WALSH MATTHEW M (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-05	Common Stock	M	22343	$28.63	Acquired	22343	Direct
2021-08-05	Common Stock	F	7653	$28.63	Disposed	14690	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-05	Restricted Stock Units	$	M	22343	Acquired	2023-08-05	Common Stock (22343)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.

F2: These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023.